Stock Analysts’ updated eps estimates for Wednesday, September 20th:

Arbutus Biopharma Corporation (NASDAQ:ABUS) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $9.00 price target on the stock.

Adobe Systems (NASDAQ:ADBE) had its overweight rating reaffirmed by analysts at KeyCorp. They currently have a $174.00 price target on the stock.

Aerie Pharmaceuticals (NASDAQ:AERI) had its buy rating reissued by analysts at Mizuho. Mizuho currently has a $70.00 target price on the stock.

Alnylam Pharmaceuticals (NASDAQ:ALNY) had its overweight rating reaffirmed by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $116.00 target price on the stock, up from their previous target price of $110.00.

Alnylam Pharmaceuticals (NASDAQ:ALNY) had its outperform rating reiterated by analysts at Cowen and Company. Cowen and Company currently has a $117.00 price target on the stock, up from their previous price target of $93.00.

Alnylam Pharmaceuticals (NASDAQ:ALNY) had its hold rating reissued by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $83.00 price target on the stock, up from their previous price target of $56.00.

Assa Abloy AB (OTCMKTS:ASAZY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Assa Abloy AB offers locks and security products. Its product offer include mechanical locks such as door locks and cylinder locks and security doors, electromechanical locks, electronic locks, door closers, door automatics, access control systems. Assa Abloy also provides secure identity solutions, contactless identification technology solutions, electronic lock systems and safes for hotels and cruise ships. The Company primarily sells in Europe and in North America. Assa Abloy AB is based in Stockholm, Sweden. “

Activision Blizzard (NASDAQ:ATVI) had its outperform rating reaffirmed by analysts at Robert W. Baird. Robert W. Baird currently has a $68.00 target price on the stock.

Best Buy Co. (NYSE:BBY) had its buy rating reissued by analysts at UBS AG. UBS AG currently has a $57.00 target price on the stock, down from their previous target price of $60.00.

China Unicom (Hong Kong) (NYSE:CHU) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “China Unicom Limited is engaged in the provision of cellular, paging, long distance, data and internet services in the People’s Repulic of China. “

Comcast Corporation (NASDAQ:CMCSA) had its outperform rating reiterated by analysts at Robert W. Baird.

FedEx Corporation (NYSE:FDX) had its buy rating reissued by analysts at Bank of America Corporation. The firm currently has a $240.00 price target on the stock.

ManTech International Corporation (NASDAQ:MANT) had its buy rating reissued by analysts at Maxim Group. Maxim Group currently has a $47.00 target price on the stock, up from their previous target price of $44.00.

The Medicines (NASDAQ:MDCO) had its buy rating reissued by analysts at Chardan Capital. They currently have a $85.00 target price on the stock.

Tronox (NASDAQ:TROX) had its sell rating reaffirmed by analysts at UBS AG. UBS AG currently has a $16.00 price target on the stock, up from their previous price target of $15.00.

United Continental Holdings (NYSE:UAL) had its buy rating reaffirmed by analysts at Stifel Nicolaus. They currently have a $110.00 price target on the stock.

Volkswagen AG (NASDAQ:VLKAY) had its market perform rating reiterated by analysts at Sanford C. Bernstein.

Western Digital Corporation (NASDAQ:WDC) had its add rating reiterated by analysts at UBS AG.

Receive News & Ratings for Arbutus Biopharma Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arbutus Biopharma Corporation and related companies with MarketBeat.com's FREE daily email newsletter.